Impact of non-adherence on the safety and efficacy of uric acid lowering therapies in the treatment of gout
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
StandardStandard
Impact of non-adherence on the safety and efficacy of uric acid lowering therapies in the treatment of gout. / Hill McManus, Daniel; Soto, Elena; Marshall, Scott et al.
Yn: British Journal of Clinical Pharmacology, Cyfrol 84, Rhif 1, 01.2018, t. 142-152.
Yn: British Journal of Clinical Pharmacology, Cyfrol 84, Rhif 1, 01.2018, t. 142-152.
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
HarvardHarvard
Hill McManus, D, Soto, E, Marshall, S, Lane, S & Hughes, D 2018, 'Impact of non-adherence on the safety and efficacy of uric acid lowering therapies in the treatment of gout', British Journal of Clinical Pharmacology, cyfrol. 84, rhif 1, tt. 142-152. https://doi.org/10.1111/bcp.13427
APA
Hill McManus, D., Soto, E., Marshall, S., Lane, S., & Hughes, D. (2018). Impact of non-adherence on the safety and efficacy of uric acid lowering therapies in the treatment of gout. British Journal of Clinical Pharmacology, 84(1), 142-152. https://doi.org/10.1111/bcp.13427
CBE
Hill McManus D, Soto E, Marshall S, Lane S, Hughes D. 2018. Impact of non-adherence on the safety and efficacy of uric acid lowering therapies in the treatment of gout. British Journal of Clinical Pharmacology. 84(1):142-152. https://doi.org/10.1111/bcp.13427
MLA
Hill McManus, Daniel et al. "Impact of non-adherence on the safety and efficacy of uric acid lowering therapies in the treatment of gout". British Journal of Clinical Pharmacology. 2018, 84(1). 142-152. https://doi.org/10.1111/bcp.13427
VancouverVancouver
Hill McManus D, Soto E, Marshall S, Lane S, Hughes D. Impact of non-adherence on the safety and efficacy of uric acid lowering therapies in the treatment of gout. British Journal of Clinical Pharmacology. 2018 Ion;84(1):142-152. Epub 2017 Hyd 10. doi: 10.1111/bcp.13427
Author
RIS
TY - JOUR
T1 - Impact of non-adherence on the safety and efficacy of uric acid lowering therapies in the treatment of gout
AU - Hill McManus, Daniel
AU - Soto, Elena
AU - Marshall, Scott
AU - Lane, Steven
AU - Hughes, Dyfrig
PY - 2018/1
Y1 - 2018/1
U2 - 10.1111/bcp.13427
DO - 10.1111/bcp.13427
M3 - Article
VL - 84
SP - 142
EP - 152
JO - British Journal of Clinical Pharmacology
JF - British Journal of Clinical Pharmacology
SN - 0306-5251
IS - 1
ER -